statement: p.E152K-STIM1 variant found in pancreatitis patients leads to intracellular changes in calcium homeostasis through SERCA interaction, enabling intracellular trypsin activation and pancreatic acinar cell death.
INTRODUCTION
Cell damage observed in experimental acute pancreatitis results in part from abnormal intracellular calcium concentrations (Ca 2+ i) (Petersen, 2009; Gerasimenko et al., 2014) . Elevated Ca 2+ i signals can be elicited by combinations of fatty acids, alcohol or bile acids, leading to the appearance of fatty acid ethyl esters, which mediate the toxic alcohol effects on pancreatic acinar cells. This higher Ca 2+ i results from the excessive release of endoplasmic reticulum (ER) Ca 2+ stores or from an increase in Ca 2+ influx such as storeoperated calcium entry (SOCE) regulated by stromal interaction molecule-1 (STIM1) and mediated by ORAI1 proteins. The sustained Ca 2+ signals and cytosolic Ca 2+ overload contribute to the development of acute pancreatitis (Gerasimenko et al., 2009; Lur et al., 2011; Wen et al., 2015) through initiating activation of intracellular proteases responsible for cell autodigestion (Raraty et al., 2000; Gerasimenko et al., 2013; Zhu et al., 2018) . Actually, the inhibition of calcium channel activity has been described as protective in pancreatitis and represents a therapeutic option (Son et al., 2019; Waldron et al., 2019) .
STIM1 is a single-pass transmembrane protein mainly localized to the ER membrane and has been established as the main ER Ca 2+ sensor in non-excitable and excitable cells (Yuan et al., 2009 ). The EF-hand and sterile α-motif (EF-SAM) domains of STIM1 are located in the luminal region of the ER and together act as a Ca 2+ sensor to initiate SOCE activation. After ER Ca 2+ store depletion, STIM1 oligomerizes and subsequently translocates to ER-plasma membrane junctions (Liou et al., 2005; Roos et al., 2005) allowing interaction with store-operated Ca 2+ channels (Wu et al., 2006; Park et al., 2009; Nwokonko et al., 2017) .
The association between STIM1 gene variants and the development of different diseases has been elucidated. Among them, we can find STIM1 variants driving to loss of function in autoimmunity and immunodeficiencies like E136X (Picard et al., 2009) and homozygous p.L74P and p.L374P (Parry et al., 2016; Vaeth et al., 2017) , or reporting a gain of function like p.D84G/p.H84N/p.H109R for tubular-aggregate myopathy (Böhm et al., 2013) , p.R304W for Stormorken syndrome (Misceo et al., 2014; Morin et al., 2014; Nesin et al., 2014) , p.I115F (Hedberg et al., 2014) and p.D84E (Noury et al., 2017) for tubular-aggregate myopathy, and p.S88G/p.R304Q for neuromuscular malfunctions (Harris et al., 2017) . The importance of Ca 2+ signaling for the regulation of pancreatic zymogen activation and the key role of STIM1 in this process suggests that variants in the STIM1 gene may also contribute to chronic pancreatitis by disturbing Ca 2+ homeostasis within the pancreatic tissue. In this regard, Sofia and colleagues have recently analyzed the STIM1 in 80 patients with idiopathic chronic pancreatitis (ICP) and found three missense mutations in different patients (Sofia et al., 2016) . Indeed, a recently genetic study of the Ca 2+ channel TRPV6 in pancreatitis cohorts described variants of the protein linked to Ca 2+ deregulation leading to the appearance of pancreatitis features (Masamune et al., 2020) .
In this article, we analyzed the calcium signaling of 37 STIM1 variants found in 3 pancreatitis patient cohorts containing 2057 patients and 3322 controls (Masson et al 2019, Genetic analysis of the STIM1 gene in chronic pancreatitis, doi: http://dx.doi.org/10.1101/691899). Extensive functional analyses of a particular variant, E152K, suggested that Ca 2+ deregulation within the pancreatic acinar cells may potentially modify the risk of chronic pancreatitis.
RESULTS

Identification of STIM1 variants in ICP patients
As described, the 37 distinct variants found in a cohort of chronic pancreatitis patients were not evenly distributed along the STIM1 amino acid sequence, approximately 65% (n = 24) of them occurring in the last 185 residues (27%) of the 685-amino acid protein ( Fig. 1A ). Whereas the 24 variant C-terminal cluster is located primarily within the poorly characterized region of STIM1 between CC3 and P/S, a small cluster comprising four variants is located between the signal peptide (S) and the first EF-hand domain (cEF). By contrast, another small cluster comprising five variants is located within a well-defined region, the SAM domain ( Fig 1A) .
Functional screening of all 37 STIM1 variants in HEK293T cells
To explore the effects of STIM1 variants on Ca 2+ flux, STIM1 variants were transiently expressed in HEK293T cells. The speed and amplitude of Ca 2+ release from ER stores and SOCE after Thapsigargin (TG) addition were then evaluated 48 h after transfection in fura-2 loaded cells (Table S1 ). As expected, over-expression of wild-type (WT) STIM1 induced an increase in the SOCE rate as compared to cells expressing an empty vector without significantly altering ER Ca 2+ release ( Fig. 1B ). Significant increases in SOCE were also observed in cells expressing p.S524F, p.P538S and p.E546K STIM1 variants in comparison to WT STIM1 ( Fig.   1B ). It should however be noted that two of the three variants, p.S524F and p.E546K, were found in both patients and controls with equal or comparable frequencies (Masson et al 2019, Genetic analysis of the STIM1 gene in chronic pancreatitis, doi: http://dx.doi.org/10.1101/691899). Surprisingly, ER Ca 2+ release induced by SERCA pump inhibition by TG was significantly increased in cells expressing STIM1 p.A38P and p.E152K compared to WT STIM1-expressing cells ( Fig. 1B,C) . We observed the same effect after tBHQ addition with respect to STIM1 p.E152K by comparison with WT STIM1-expressing cells (Fig. S1A ).
The p.E152K variant was of particular interest for three reasons. First, it was observed in three patients but not in controls (Table S1 ). It should also be pointed out that p.E152K is extremely rare in the general population; its average allele frequency in gnomAD (gnomad.broadinstitute.org/) was 0.0001162 (30/258080; as of November 30, 2018) . Second, p.E152K affects a highly conserved amino acid of the EF-SAM domain located within the 7th α-helix (Fig. S1B ). The highly conserved EF-SAM domain is central to STIM1 oligomerization (Stathopulos et al., 2006) . Gain of function variants in the EF-hand domain have been previously reported to induce constitutive STIM1 oligomerization and have been associated with tubularaggregate myopathy (Böhm et al., 2013; Hedberg et al., 2014; Lacruz and Feske, 2015) . Third, and somewhat intriguingly, all three patients harboring the STIM1 p.E152K variant were found to harbor heterozygous variants in other known chronic pancreatitis susceptibility genes. Thus, of the two French patients, one harbored PRSS1 p.N29I whereas the other harbored PRSS1 p.P36R. Both PRSS1 p.N29I and PRSS1 p.P36R are rare variants whereas PRSS1 p.N29I is a well-known pathogenic mutation; PRSS1 p.P36R is currently classified as benign (see the Genetic Risk Factors in Chronic Pancreatitis Database; http://www.pancreasgenetics.org/index.php). In the Chinese patient harboring the STIM1 p.E152K variant, the situation is more complicated: the patient also harbored the SPINK1 c.194+2T>C variant, the PRSS1 c.623G>C (p.G208A) variant and the CTRC c.180C>T (p.G60=) variant; all three of the latter variants have been recently shown to be associated with chronic pancreatitis in a large Chinese cohort study (Zou et al., 2018) .
In view of the aforementioned points, we focused our functional exploration on the p.E152K variant.
Ca 2+ signaling deregulation in fibroblasts obtained from an ICP patient harboring the p.E152K variant
Fibroblasts were obtained from the patient carrying the STIM1 p.E152K variant and the PRSS1 p.P36R variant (II.2), his mother who harbored neither of the two variants (I.2) and his brother (II.1) carrying only the PRSS1 p.P36R variant ( Fig. 2A ). Clear and significant increases in the speed and amplitude of the ER Ca 2+ release as well as the SOCE rate were observed in fibroblasts from the patient as compared to the two aforementioned relatives ( Fig. 2B ).
Modulation of ER Ca 2+ homeostasis in HEK293T cells expressing the p.E152K variant
One possible explanation for the increased ER Ca 2+ release is enhanced passive Ca 2+ leakage from the ER when TG blocks SERCA. However, receptor-mediated Ca 2+ release consequent to the activation of InsP3 receptors (InsP3Rs) following carbachol (CCh) stimulation ( Next, we directly monitored changes in ER Ca 2+ concentration in HEK293T cells transfected with the ERtargeted cameleon probe D1ER (Palmer et al., 2004) . ER Ca 2+ concentration ([Ca 2+ ]er) was determined after D1ER titration (Fig. S1E) as previously described (Shen et al., 2011) . The simplest explanation for the increase in ER Ca 2+ release is that a higher Ca 2+ er enhances the driving force for the ER Ca 2+ efflux. No significant increase in Ca 2+ er was observed when over-expressing WT STIM1 or STIM1-T153I ( Fig. 3C ).
However, ER Ca 2+ concentration was markedly increased in cells expressing STIM1-E152K as compared to WT STIM1 (Fig. 3C , 484 vs 363 μM, P < 0.05). After blocking SERCA using TG, a significant enhancement (P < 0.001) of both the rate (36%) and amplitude (23%) of Ca 2+ er decrease was only observed in STIM1-E152Kexpressing cells (Fig. 3D ).
Interaction between SERCA and STIM1 modulates SERCA activity and ER refilling
An increase in SERCA pump activity would explain the increase in Ca 2+ er and Ca 2+ efflux in cells expressing STIM1-E152K. SERCA pump activity, estimated by quantifying ER Ca 2+ refilling following store depletion with tBHQ in permeabilized and non-permeabilized D1ER-expressing cells ( Fig. 4A,B ), is clearly enhanced in STIM1-E152K-expressing cells independently of SOCE as demonstrated by experiments performed under permeabilizing conditions.
Hence, we hypothesized that SERCA activity can be directly regulated by STIM1. Different studies have reported the interaction of STIM1 with SERCA2 and SERCA3 pumps (López et al., 2008; Sampieri et al., 2009; Manjarrés et al., 2010) . Using a FRET-based SERCA construct (Satoh et al., 2011; Hou et al., 2012; Pallikkuth et al., 2013) , we sought to establish whether the stronger association between SERCA and STIM1-E152K could modulate SERCA conformational state changes. At rest, a basal FRET level is seen, whereas after tBHQ addition, the FRET signal decreases as the SERCA cytoplasmic headpiece is driven to an "opened" conformation (Hou et al., 2012) . Remarkably, we observed a reduction in the basal FRET/GFP ratio in cells over-expressing WT STIM1 in comparison to empty vector, and an even lower ratio in cells expressing E152K-STIM1 ( Fig. 4C ). After tBHQ addition, the amplitude and rate of SERCA conformational change is higher in E152K expressing cells than WT. The maximal rate of FRET/GFP decrease induced by Ca 2+ store release was significantly enhanced in cells expressing STIM1-E152K. In terms of amplitude, both WT STIM1 and STIM1-E152K diminished the FRET/GFP decrease induced by tBHQ, E152K having a stronger effect.
When ER Ca 2+ was depleted, SERCA displayed a more rapid conformational change in the presence of STIM1-E152K in comparison to WT STIM1, although smaller in amplitude.
To reinforce our hypothesis of a modification of STIM1/SERCA interaction in the presence of E152K variant, we performed immunoprecipitation experiments. STIM1 and SERCA co-immunoprecipitate under resting conditions and the association is increased after store depletion when WT STIM1 is overexpressed ( Fig. 4D ). Interestingly, an increase in SERCA/STIM1 co-immunoprecipitation was observed in STIM1-E152Kexpressing cells as compared to cells expressing WT STIM1 after TG treatment ( Fig. 4D ). Taken together, these results suggest that under resting Ca 2+ er conditions, a fraction of STIM1 is already associated with SERCA. When Ca 2+ er is lowered, an enhanced functional association between the STIM1-E152K and SERCA compared to WT STIM1 may then increase this Ca 2+ pump activity and modulate its Ca 2+ affinity resulting in a higher Ca 2+ er.
Taken together, these data suggest that the p.E152K variant modifies the degree of association between SERCA and STIM1. Among other explanations, the greater STIM1-E152K association with SERCA before store depletion could favour an intermediate cytoplasmic conformational state which responds faster after Ca 2+ depletion.
Intrinsic biophysical properties of STIM1-E152K
It is now well established that the EF-SAM domain plays a critical role in the regulation of STIM1 oligomerization (Stathopulos et al., 2006) . Computational modelling of STIM1 for both the WT and the p.E152K variant to discern possible changes in the mutated STIM1 structure (Supplementary note and Fig.   S2 ) suggest that a difference in local charge due to the p.E152K mutation may affect STIM1 protein-protein interactions. Using a FRET approach, we observed a difference in FRET multimerisation between WT and E152K mutated STIM1. We observed a significantly higher FRET level between CFP-STIM1-E152K and YFP-STIM1-E152K by comparison with the CFP-WT STIM1/YFP-WT STIM1 constructs, consistent with an increased efficiency of STIM1-E152K homo-oligomerization ( Figure 5a ). FRET analysis of WT-STIM1/E152K mutated STIM1 multimerization as expected in an heterologous expression condition, is not relevant due to the higher homo-oligomerization efficiency of mutated STIM1 compared to WT STIM1 that will bias CFP-WT/YFP-E152K FRET data interpretation.
Biophysical analyses were then performed on purified EF-SAM domains of WT or mutated human STIM1 ( Fig. S3A ). Far-UV circular dichroism (CD) experiments confirmed that the mutant EF-SAM domains retain the ability to sense Ca 2+ changes through a marked alteration in structure, consistent with the ability of fulllength STIM1 E152K to signal SOCE after ER Ca 2+ store depletion ( Fig. S3B ). Thermal stability studies of the EF-SAM domains revealed that the E152K variant destabilized the Ca 2+ -bound EF-SAM structure (Tm WT = 53˚C versus Tm E152K = 49.5˚C, Fig. 5B left subpanel) . In contrast, the E152K variant appeared to stabilize the Ca 2+ -depleted EF-SAM structure (Tm WT ~ 23˚C versus Tm E152K ~ 27˚C, Figure 5b right subpanel), with the caveat that both the WT and E152K data showed a high variability due to the overall instability. These results suggest that the enhanced multimerization displayed by E152K STIM1 as compared to WT may be due to the destabilized Ca 2+ -loaded state which more readily undergoes a transition to the oligomerizationprone Ca 2+ -depleted state and/or a modified Ca 2+ -depleted state with enhanced oligomer stability.
Size exclusion chromatography with in-line multiangle light scattering (SEC-MALS) allowed us to conclude that in the presence of Ca 2+ , E152K EF-SAM exists primarily as a monomer, but undergoes a shift in the self-association equilibrium towards dimers and oligomers in the absence of Ca 2+ as observed for WT STIM1 and T153I EF-SAM ( Fig. S3C ). No significant change in the Ca 2+ binding affinity of E152K STIM1 was observed and the measured affinities were in the same range as those previously reported for WT STIM1 EF-SAM (Stathopulos et al., 2006) (Fig. 5D ). Taken together, these data suggest that the E152K EF-SAM variant displays WT-like Ca 2+ sensitivity characteristics in terms of Ca 2+ binding, secondary structure and oligomerization. However, changes in the stability of STIM1 E152K EF-SAM with and without Ca 2+ may contribute to aberrant ER Ca 2+ homeostasis and differences in STIM1 protein interactions. The biophysical properties of the different EF-SAM domains are summarized in Fig. 5D .
Functional consequences of E152K STIM1 in rat pancreatic acinar cells
In order to probe the physiological consequences of STIM1-E152K expression with a view to potentially linking the observed defects in Ca 2+ signaling to pancreatitis, we next evaluated, in rat pancreatic AR42J cells, the effects of the STIM1 p.E152K variant on Ca 2+ signaling, trypsin activation, trypsinogen secretion and the subsequent consequences for cell fate. As observed in HEK293T cells, a significant increase in the rate and amplitude of ER Ca 2+ release induced by agonist stimulation with cholecystokinin (CCK) (Fig. 6A) or Cch (Fig. S4A ) or by TG ( Fig. S4B ) was obtained in AR42J cells expressing STIM1-E152K ( Fig. S4C ).
Intra-acinar activation of zymogens is a key event in the initiation of acute pancreatitis (Krüger et al., 2000) and the increased Ca 2+ mobilization observed in STIM1-E152K-expressing cells may lead to an increase in intracellular trypsin activation after stimulation. Trypsin activation was monitored before and after CCK stimulation using the BZiPAR probe (Raraty et al., 2000) , which allowed us to detect constitutive activation of trypsin in AR42J cells that was enhanced following CCK stimulation in a time-dependent manner ( Fig. 6B) but was prevented by pretreatment with benzamidine, a competitive inhibitor of trypsin ( Fig. S4D) . A higher amount of basal activated trypsin as well as a significant enhancement of trypsin activation after 4 h stimulation was detected in AR42J cells expressing STIM1-E152K as compared to WT STIM1 or empty vector ( Fig. 6B ) (12% increase in basal trypsin activity and 49% increase after 4h CCK treatment respectively, P < 0.001).
Another explanation proposed for cell degradation observed in pancreatitis is a decrease in Ca 2+dependent trypsinogen secretion (Gerasimenko et al., 2014) . Trypsin cellular content and exocytosis were evaluated as previously described by Western blot of cell lysates and in conditioned media after CCK treatment of AR42J cells expressing PRSS1 (Kereszturi and Sahin-Tóth, 2009 ). An enhancement of intracellular trypsin and a decrease in trypsin secretion was observed in cells expressing STIM1-E152K as compared to cells transfected with WT STIM1 in this experiment after CCK treatment, suggesting a difference in trypsin secretion when E152K variant was present ( Fig. 6C ). In agreement with these findings, the basal level of toxicity was higher in cells expressing STIM1-E152K as compared to cells transfected with an empty vector, WT STIM1 or STIM1-T153I (Fig. 6D ). An enhancement of cell toxicity following CCK stimulation was observed in AR42J cells expressing STIM1-E152K in comparison to WT STIM1, in agreement with the increase in trypsin auto-activation observed under the same conditions (Fig. 6B ).
DISCUSSION
Notably, none of the identified 37 rare STIM1 variants identified in the 3 pancreatitis patients cohorts correspond to those previously reported to cause or predispose to other diseases (Lacruz and Feske, 2015) , potentially strengthening the notion of the tissue-specific effects of different STIM1 variants. However, functional screening of these variants in relation to the speed and amplitude of Ca 2+ release from ER stores and SOCE failed to reveal any enrichment of functional variants in patients. This may reflect a common challenge that we face in the functional annotation of disease-predisposing or modifying variants that may either only subtly affect gene expression or protein structure and function, or alternatively may exert their effects in tissue-or cell type-dependent fashion. Nonetheless, extensive functional analysis of one particular variant, p.E152K, which was found in three patients (two French and one Chinese) but not in any of the 3,322 controls, established a plausible link between dysregulated Ca 2+ signaling within the pancreatic acinar cells and chronic pancreatitis susceptibility. Since all three patients harboring the STIM1 p.E152K variant also harbored variants in known chronic pancreatitis susceptibility genes in the trypsin-dependent pathway, the STIM1 p.E152K variant may be acting as a disease modifier.
E152K is located in the EF-SAM domain, a region previously identified as being crucial for STIM1 function. So far, the role of the STIM1 EF-SAM domain has been uniquely associated with SOCE activation (Stathopulos et al., 2006; Stathopulos et al., 2008) whereas gain of function mutations in the EF-hand domain have only been associated with the constitutive activation of STIM1 and SOCE (Böhm et al., 2013; Lacruz and Feske, 2015; Noury et al., 2017) . Here, we reveal a gain of function for the STIM1-E152K variant potentially caused by altered interactions with SERCA rather than enhanced EF-SAM oligomerization. This modification leads to deregulated calcium homeostasis through its interaction with SERCA and trypsin autoactivation, thereby triggering cell death. SERCA has been previously shown to interact with STIM1 and has been determined to be a fundamental component of the store-operated Ca 2+ influx complex (SOCIC) formed by channels and proteins regulating SOCE and store refilling (Jousset et al., 2007; López et al., 2008; Manjarrés et al., 2010; Vaca, 2010) .
The enhancement of SERCA pump activity after store depletion explains the increase in [Ca 2+ ]ER and Ca 2+ release observed in STIM1-E152K-expressing cells. As proposed by Lopez and colleagues (López et al., 2008) , STIM1 is already associated directly or indirectly with SERCA before store depletion under our experimental conditions. However, our study is the first to propose regulation of the SERCA pump by STIM1-mediated STIM1/SERCA physical interaction. We propose that the increased association between SERCA and STIM1-E152K, under resting conditions or after ER Ca 2+ depletion, is responsible for the enhancement of SERCA pump activity and subsequently for the amplification of [Ca 2+ ]ER and ER Ca 2+ release. An E152K variant favors the cytoplasmic "opened" state which occurs prior to the conformational change after Ca 2+ depletion.
Regulation of Ca 2+ pump function via a physical interaction was previously demonstrated for the plasma membrane Ca 2+ ATPase (PMCA) (Ritchie et al., 2012) .
It is now clearly established that the cell damage observed in pancreatitis originates from an abnormal increase or maintained level of Ca 2+ i (Petersen, 2009) . Initial release of Ca 2+ from both the ER and acidic pools in the apical region of pancreatic acinar cells is the critical starting point for the Ca 2+ -dependent activation of pro-enzymes such as trypsinogen. Expressing the STIM1-E152K variant in AR42J pancreatic cells clearly induces excessive Ca 2+ release from the ER after cell stimulation that could be correlated with the cytotoxicity observed under these conditions, resulting from an increased basal trypsin activity along with decreased secretion of its trypsinogen precursor after cell stimulation. Regulation of cationic trypsinogen degradation and auto-activation along with trypsin inactivation are key protective mechanisms from pancreatic injury reported as being sensitive to Ca 2+ (Szmola and Sahin-Tóth, 2007; Szabó et al., 2014) .
In pancreatic acinar cells, the role of Ca 2+ in zymogen granule secretion is well established (Messenger et al., 2014) . The main role of ER Ca 2+ release in the apical granular region of pancreatic acinar cells is to generate Ca 2+ transients in local micro-domains to activate acinar fluid and enzyme secretion by exocytosis (Maruyama et al., 1993; Maruyama and Petersen, 1994; Petersen, 2015) . Tightly regulated apical ER SERCA pump activity is therefore crucial for providing an optimal environment for controlled local Ca 2+ signaling and regulated zymogen exocytosis. Excessive release of Ca 2+ from the ER and subsequent perturbation in apical Ca 2+ micro-domains have been linked to the major apical region structural and functional disorganization observed in pancreatitis such as the appearance of endocytic vacuoles in which trypsinogen has been transformed to active trypsin and mitochondrial depolarization (Gerasimenko et al., 2009; Petersen, 2015) . Taken together, we surmise that the expression of some gain of function STIM1 variants that enhance ER Ca 2+ release may promote acinar cell damage thereby contributing to the etiology of chronic pancreatitis.
In summary, we have provided a number of pieces of evidence to support the view that a STIM1 variant, p.E152K, could act as a disease modifier by causing specific changes in Ca 2+ homeostasis that in turn increase intracellular trypsin activation and cell death. This finding may prompt new lines of research into ICP as well as opening new avenues for future therapeutic studies into the development of drugs designed to modulate Ca 2+ signaling, with a view to preventing or at least delaying the transition from acute pancreatitis to chronic pancreatitis (Wen et al., 2015) . Moreover, the identification of the STIM1 p.E152K variant together with three known disease-predisposing variants (in three different trypsin-dependent pathway genes) in a same patient provided an exceptionally illustrative example for the complex etiology of chronic pancreatitis. Finally, this study led to the identification of a previously undescribed interaction between the STIM1 EF-SAM domain and SERCA, thereby generating new insights into the structure and function of STIM1.
Material and Methods
Reagents
Thapsigargin, cholecystokinin, carbachol, ATP, benzamidine, tBHQ, CCCP and digitonin were obtained from Sigma. Fura-2 BZiPAR and Protein G magnetic beads were from Invitrogen -Thermo Fisher Scientific 
Construction of STIM1 cDNA expression vector and mutagenesis
RNA was extracted with Trizol (Invitrogen, Carlsbad, CA) from Colo-357 cells. The SuperScript® II Reverse Transcriptase, random hexamers (Qiagen, Courtaboeuf, France) and 2 µg RNA were used to synthesize first strand cDNA. RT-PCR was performed using the Phusion® High-Fidelity DNA Polymerase (NEB, Evry, France) according to the manufacturer's protocol in a 50-μl reaction mixture using forward primer 5'-ATGGATGTATGCGTCCGTCT-3' and reverse primer 5'-CTACTTCTTAAGAGGCTTCT-3'. The PCR program comprised an initial denaturation at 98°C for 30 secs, followed by 40 cycles denaturation at 98°C for 20 secs, annealing at 62°C for 20 secs and extension at 72°C for 90 secs, with a final extension at 72°C for 5 min.
After migration in a 1% agarose gel, the expected band (2,058bp) was purified using the MinElute PCR Purification Kit (Qiagen, Courtaboeuf, France). After adding the 3' A-overhangs to the PCR purified product, the STIM1 cDNA was cloned into the pcDNA3.1/V5-His TOPO TA vector (Invitrogen, Cergy-Pontoise, France).
All STIM1 variants were generated from the wild-type (WT) construct by site-directed mutagenesis using the QuikChange II XL Site-Directed Mutagenesis Kit (Stratagene, Massy, France). All resulting plasmids were checked by Sanger sequencing.
Extraction of fibroblasts
Skin biopsies were washed in PBS, cut into small pieces and placed on 60 mm coated plates (Corning® CellBIND® Surface, Corning). Fibroblast expansion was made in DMEM completed with 10% FBS and 100 U/ml penicillin/streptomycin in a humidified incubator with 5% CO2 at 37°C. After the fibroblasts had colonized the plate, explants were removed, and fibroblasts expanded. At confluence, cells were trypsinized. Cells were used from passages 3 to 6, and placed on coverslips for image analysis.
Cytosolic Ca 2+ measurements
Cells were plated on 18 mm glass cover slips. Changes in cytosolic Ca 2+ concentration were measured with Fura-2 (ThermoFisher, Waltham, MA). Cells were loaded with 4 µM Fura-2/AM for 45 min in the dark at room temperature in a medium containing 135 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, 10 mM Hepes, 10 mM glucose, pH 7.4. Cells were washed and equilibrated for 15 min in the same buffer to allow de-esterification of the dye. Ratiometric images of Ca 2+ signals were obtained at room temperature using a microscope (IX71, Olympus) equipped with a monochromator illumination system (Polychrome V, TILL Photonics). Cells were illuminated alternately at 340/380 nm and emission was collected every 3 seconds through a 415DCLP dichroic mirror at 435 nm by a 14-bit CCD camera (EXiBlue, Qimaging). Image acquisition and analysis were performed with the Metafluor 6.3 software (Universal Imaging, West Chester, PA). The Excitation/Emission ratio was calculated for each cell. For normalization, the formula (F-F0)/F0, was used, where F is the Excitation/Emission ratio of each value and F0 is the initial ratio. The Ca 2+ -free solution contained 1mM EGTA instead of 1.8 mM CaCl2.
ER Ca 2+ measurements
HEK293T cells were transiently transfected using LipoD293 (tebu-bio) with 2 μg cDNA encoding the D1-ER construct 48 h before the experiments. Ratiometric images of Ca 2+ signals were obtained using a microscope (Axio Observer, Zeiss) equipped with a Lambda DG4 illumination system (Sutter Instrument Company, Novato, CA) as previously described (Philippe et al., 2015) . In situ calibration of the D1-ER was performed in medium containing 10 mM NaCl, 135 mM KCl, 1 mM MgCl2, 20 mM sucrose, 20 mM Hepes, 0.01 mM digitonin, 0.01 mM ionomycin, 0.005 mM CCCP (pH 7.1 with NaOH). 5 mM EGTA and 5 mM EDTA were used to buffer free [Ca 2+ ] below 100 µM, and 10 mM EDTA to buffer free [Ca 2+ ] between 100 µM and 1 mM (Max Chelator Winmaxc version 2.51). To evaluate the resting ER Ca 2+ concentration, minimum and a maximum D1ER fluorescence values were measured at the end of each experiment. To quantify ER Ca 2+ refilling, the slope of the increase of FRET signal was determined by a linear fit. To measure Ca 2+ leak rates of the ER, passive ER depletion was induced by thapsigargin and the D1ER responses were fitted with a one-phase exponential decay function to extract the half-time (τ1/2).
Permeabilized HEK cells: after ER Ca 2+ depletion by 15 µM tBHQ (15 min in Ca 2+ -free medium), cells were permeabilized by the addition of 60 µM digitonin (1 min). ER Ca 2+ refilling was then measured by allowing them to recover in intracellular buffer before the addition of 100nM CaCl2 plus 2.5 µM CCCP (to block mitochondrial Ca 2+ uptake). To mimic cytosolic ionic composition in these permeabilizing experiments, HEK293T cells were washed with high K + intracellular buffer, containing 110 mM KCl, 10 mM NaCl, 0.5 mM K2HPO4, 5 mM succinate, 10 mM HEPES (pH 7.0 at 37 °C), supplemented with 5 mM EDTA or 1 mM EGTA.
100nM [Ca 2+ ] was calculated using the Maxchelator program.
Assessment of SERCA conformational changes
FRET imaging experiments were performed using an epifluorescence inverted microscope (DMIRE-2, Leica) with a PlanApo 40x oil immersion objective. The excitation light source was a high-speed scanning polychromator with a Xe lamp (C7773, Hamamatsu Photonics). An emission filter wheel was controlled by a Lambda-10 device (Sutter Instruments). Images were acquired with an ORCA-FLASH 4.0 camera (C11440-22CU) and Aquacosmos 2.6 software was used to control all devices. Both camera and software were from Hamamatsu Photonics. ImageJ software was used for analyses.
Cells were plated in 35 mm ibidi µ-dishes, and transfected with lipofectamine 2000. The SERCA2a
conformation sensor was labelled with GFP in the N-terminus and tagRFP in the nucleotide domain.
Transfections were performed using RG-SERCA and either empty vector, CFP-WT STIM1 or CFP-E152K-STIM1 (1 µg:0.5 µg DNA). Cells were perfused in a medium containing: 135 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, 10 mM Hepes, 10 mM glucose, pH 7.4. The Ca 2+free solution contained 1mM EGTA instead of 1.8 mM CaCl2. Cells were illuminated at 500 nm through an excitation filter (422/503/572 nm) and a triple-edge dichroic mirror (422/520/590 nm). FRET and donor emissions were alternately collected with emission filters 620/52 nm and 535/22 nm (center wavelength/bandwidth), respectively. A ratio of FRET image (donor excitation, acceptor emission) and donor image (GFP) (donor excitation, donor emission) was calculated, after subtracting background in both channels for its analysis. STIM1 expression was checked by excitation at 430 nm whilst emission was collected with emission filter 475/20 nm.
Western blotting
Cells were washed in ice-cold PBS and lysed with RIPA buffer containing protease inhibitor cocktail at 4°C for 30 min. Cell lysates were centrifuged at 16,000g for 10 min at 4ºC, and supernatants were collected. Cell lysates (100 µg) were loaded, separated in acrylamide SDS-PAGE gel (gradient 4-12%), and transferred to PVDF membrane. For experiments designed to evaluate trypsin secretion, the conditioned media were treated with trichloroacetic acid for protein precipitation and washed three times in acetone. Blots were incubated with anti-PRSS1 antibody (1:1000), anti-STIM1 antibody (1:1000) or anti-GAPDH antibody (1:2000) and probed with a peroxidase-conjugated anti-mouse antibody (1:2000) or anti-sheep secondary antibody (1:2000) . An enhanced chemiluminescence system was used for visualization.
Immunoprecipitation
Anti-GOK/STIM1 antibody was coupled to Protein G magnetic beads (Invitrogen) by incubating 2.5 µg antibody with the beads (30 µl) for 1 hour at 4°C. Cells were washed in ice-cold PBS and treated with lysis buffer containing protease inhibitor cocktail at 4°C for 30 min. Cell lysates were centrifuged at 14000 g for 30 min at 4°C after sonication, and supernatants were collected. Cell lysates (500 mg) were added into the beads coupled to the antibody and incubated under gently agitation overnight at 4°C. Precipitated proteins were eluted with SDS-sample buffer and incubated at 70°C for 10 min.
STIM1 Oligomerization
1 µg of CFP-STIM1 constructs and 3 µg YFP-STIM1 constructs were co-transfected and cells were imaged 48 h after transfection. The oligomerization of STIM1 was followed by measuring the FRET signal between CFPand YFP-STIM1. Cells were excited at 430 nm through a 455-nm dichroic mirror (455DRLP, Omega Optical), and emission was collected alternatively at 480 and 535 nm (480AF30 and 535DF25, Omega Optical).
Bzipar assay
Cells were incubated with 100 µM of the trypsin substrate BZiPAR (Thermo Fisher Scientific, Waltham, MA) for 120 min. Cells were excited at 494 nm for 150 ms, and fluorescence emission was collected at 535 nm. A T510lpxrxt dichroic filter and an ET535/50 emission filter both from Chroma Technology (Bellows Falls, VT)] were used. Trypsin was added to confirm the increase in fluorescence signal when BZiPAR was present. The trypsin inhibitor benzamidine (5 ug/ml) was used to check specific trypsin response. The fluorescence (excitation 494-emission 535 nm) was measured from each cell to compare among conditions.
Cytotoxicity assay
Cell toxicity was measured using the CellTox™ Green Cytotoxicity Assay kit (Promega), and results were normalized to living cell numbers as evaluated with the CellTiter 96® AQueous One Solution Cell
Proliferation Assay Kit (Promega) following the manufacturer's instructions. Absorbance, which is proportional to living cell numbers, was measured at 490 nm. The cell cytotoxicity test is based on cellular membrane integrity using a cyanine dye with significant affinity for the DNA of dying cells. The dye properties are modified when fixed to DNA and fluorescence is enhanced. Emitted fluorescence (excitation: 512 nm, emission: 532 nm) is proportional to cell cytotoxicity and was measured for each experimental condition at different time points following the manufacturer's instructions. Cytotoxicity results were normalized using cell titration data.
Recombinant EF-SAM protein expression and purification
The T153I and E152K variants were separately introduced into pET-28a expression vectors using the Quikchange protocol (Agilent, Inc.). The pET-28a vectors were transformed into BL21 DE3 CodonPlus E. coli cells by heat shock, and liquid Luria-Bertani cultures were grown at 37ºC until the optical density (600nm) reached 0.6. Protein expression was subsequently induced with 0.3 mM isopropyl beta-Dthiogalactopyranoside and allowed to progress overnight. The hexahistidine (His6)-tagged proteins of interest were captured from E. coli cell lysate using Ni-nitriloacetic acid agarose resin (Qiagen) under denaturing conditions according to the manufacturer's guidelines. EF-SAM was refolded by dilution into 20mM Tris, 150mM NaCl, 5mM CaCl2, pH 8. Subsequently, the His6-tags were cleaved by thrombin digestion and a final size exclusion chromatography purification step using a Superdex 200 10/300 GL column linked with an AKTA FPLC (GE Healthcare, Inc.) was performed to achieve a purity of > 95%.
Far-UV-CD
CD data were acquired on a Jasco J-815 CD spectrometer (Jasco, Inc.) collected in 1 nm increments (20 nm min-1) using a 0.1 cm path length cuvette, 8 s averaging time, and 1 nm bandwidth at 20 °C. Thermal melts were acquired by monitoring the change in the 225 nm CD signal as a function of temperature (i.e. 4-75 ˚C) using 0.1 cm cuvettes, 8 s averaging time, 1 nm bandwidth and 1 ˚C min-1 scan rate. Spectra were corrected for buffer contributions.
SEC-MALS
MALS measurements were performed in-line with the size exclusion chromatography using a three angle (i.e. 45°, 90° and 135°) miniDawn light scattering instrument equipped with a 690nm laser and an Optilab rEX differential refractometer (Wyatt Technologies, Inc.). Molecular weight was calculated using ASTRA software (Wyatt Technologies, Inc.) based on Zimm plot analysis and using a protein refractive index increment, dndc -1 = 0.185 L g-1.
Statistical analyses
Sets of functional analytic data were compared using analysis of variance (ANOVA) or a Student's t-test. *, P < 0.05; ** P < 0.001; *** P < 0.0005; **** P <0.0001. Data shown were from at least four independent experiments.
Computational methodology is described in detail in Supp. materials and methods. traces of Ca 2+ er variation after addition of 1 µm TG (Ca 2+ -free medium) to D1ER-transfected HEK293T cells expressing WT STIM1 or E152K STIM1 (left hand panel). Center panel, quantification of the ER Ca 2+ release rate ( 1/2) in cells expressing WT STIM1, E152K STIM1, T153I STIM1 or empty vector. Right hand panel, quantification of the amplitude of Ca 2+ ER release after TG (1µM) treatment in cells expressing WT STIM1, E152K STIM1, T153I STIM1 or empty vector, n = 42 (empty vector), 106 (WT), 76 (E152K) and 54 (T153I). variant. (A, B) Cells were transfected with either WT or E152K STIM1; ER Ca 2+ changes were evaluated in cells transfected with ER-targeted cameleon probe D1ER. In (A), ER Ca 2+ depletion was induced by 15 µM tBHQ, and ER Ca 2+ refilling was evaluated by changing intracellular expression and its presence in the conditioned medium before and after stimulation with CCK (1 nM) of cells expressing E152K or WT STIM1. (D) Quantification over time of fluorescence signal evaluating cytotoxicity (celltox) in cells transfected with E152K STIM1, T153I STIM1, WT STIM1 or an empty vector after CCK addition (1 nM). Cell toxicity was measured using the CellTox™ Green Cytotoxicity Assay kit (Promega), and results were normalized to living cell numbers as evaluated with the CellTiter 96® AQueous One Solution Cell Proliferation Assay Kit (Promega) following the manufacturer's instructions.
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